Antibodies that potently neutralize highly diverse HIV-1 variants offer great potential for therapy and prevention. Passive administration of HIV-specific neutralizing antibodies genetically modified to have a long serum half-life has now been shown to confer long-lasting protection from infection in the rhesus macaque model.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gautam, R. et al. Nature 533, 105–109 (2016).
Gautam, R. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0001-2 (2018).
Ko, S. Y. et al. Nature 514, 642–645 (2014).
Ledgerwood, J. E. et al. Clin. Exp. Immunol. 182, 289–301 (2015).
Caskey, M. et al. Nature 522, 487–491 (2015).
Caskey, M. et al. Nat. Med. 23, 185–191 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Zanoni, M., Palesch, D. & Silvestri, G. Longing for HIV protection. Nat Microbiol 3, 648–649 (2018). https://doi.org/10.1038/s41564-018-0169-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-018-0169-8